Compounds > tolvaptan
Page last updated: 2024-09-05

tolvaptan and Cardiovascular Stroke

tolvaptan has been researched along with Cardiovascular Stroke in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (37.50)29.6817
2010's4 (50.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Akabane, M; Ishii, Y; Miki, K; Nakamura, Y; Yokoyama, T1
Morishima, I; Takagi, K; Terada, K; Tsuboi, H1
Fujiki, H; Hanatani, A; Iwao, H; Izumi, Y; Miura, K; Nakamura, Y; Osada-Oka, M; Shimada, K; Shiota, M; Yamazaki, T; Yoshiyama, M1
Eguchi, A; Hirotani, S; Iwasaku, T; Mano, T; Masuyama, T; Naito, Y; Okuhara, Y1
Fujiki, H; Hanatani, A; Iwao, H; Izumi, Y; Nakamura, Y; Osada-Oka, M; Shimada, K; Shiota, M; Yamashita, N; Yamazaki, T; Yoshiyama, M1
SoRelle, R1
Horowitz, J; Kaski, JC; McMurray, JJ; Recio-Mayoral, A; Remme, WJ; van Veldhuisen, DJ1
Achtari Jeanneret, L; Barras-Moret, AC; Carron, P; Deriaz-Chessex, S; Donzé, J; Fournier, Y; Gachoud, D; Moix, PA; Monti, M; Rossier, A; Wilson, P1

Other Studies

8 other study(ies) available for tolvaptan and Cardiovascular Stroke

ArticleYear
Usefulness of Tolvaptan for the Postoperative Control After Kidney Transplantation in a Patient With Cardiac Hypofunction: A Case Report.
    Transplantation proceedings, 2021, Volume: 53, Issue:4

    Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Cardiac Output, Low; Heart Failure; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Myocardial Infarction; Postoperative Complications; Renal Dialysis; Tolvaptan

2021
Successful Medical Treatment Using Tolvaptan of Ventricular Septal Rupture Following Myocardial Infarction.
    Internal medicine (Tokyo, Japan), 2017, Sep-15, Volume: 56, Issue:18

    Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Male; Myocardial Infarction; Tolvaptan; Ventricular Septal Rupture

2017
Tolvaptan attenuates left ventricular fibrosis after acute myocardial infarction in rats.
    Journal of pharmacological sciences, 2013, Sep-20, Volume: 123, Issue:1

    Topics: Acute-Phase Reaction; Animals; Benzazepines; Disease Models, Animal; Drug Therapy, Combination; Fibrosis; Furosemide; Heart Failure; Heart Ventricles; Male; Myocardial Infarction; Rats; Rats, Wistar; Tolvaptan; Ventricular Dysfunction, Left; Ventricular Remodeling

2013
Long-term administration of tolvaptan increases myocardial remodeling and mortality via exacerbation of congestion in mice heart failure model after myocardial infarction.
    International journal of cardiology, 2016, Oct-15, Volume: 221

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Disease Models, Animal; Heart Failure; Lung Diseases; Male; Mice; Mice, Inbred C57BL; Mortality; Myocardial Infarction; Random Allocation; Time Factors; Tolvaptan; Ventricular Remodeling

2016
Tolvaptan improves left ventricular dysfunction after myocardial infarction in rats.
    Circulation. Heart failure, 2012, Volume: 5, Issue:6

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Furosemide; Hemodynamics; Male; Myocardial Infarction; Rats; Rats, Wistar; Sodium Potassium Chloride Symporter Inhibitors; Stroke Volume; Tolvaptan; Treatment Outcome; Ventricular Dysfunction, Left

2012
Rofecoxib use increases acute myocardial infarction risk.
    Circulation, 2004, May-04, Volume: 109, Issue:17

    Topics: Aortic Aneurysm, Abdominal; Benzazepines; Cardiology; Cholesterol; Female; Heart Failure; Humans; Lactones; Male; Myocardial Infarction; Seasons; Sulfones; Tolvaptan

2004
Clinical trials update from the European Society of Cardiology Congress in Vienna, 2007: PROSPECT, EVEREST, ARISE, ALOFT, FINESSE, Prague-8, CARESS in MI and ACUITY.
    Cardiovascular drugs and therapy, 2007, Volume: 21, Issue:6

    Topics: Abciximab; Acute Coronary Syndrome; Amides; Antibodies, Monoclonal; Benzazepines; Clinical Trials as Topic; Clopidogrel; Electrocardiography; Europe; Fumarates; Heart Diseases; Heart Failure; Hirudins; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptide Fragments; Probucol; Recombinant Proteins; Ticlopidine; Tolvaptan

2007
[Highlights 2007 in hospital-based internal medicine: the point of view from the chief residents].
    Revue medicale suisse, 2008, Jan-30, Volume: 4, Issue:142

    Topics: Accidental Falls; Aged; Albuterol; Anemia; Anticoagulants; Antidiuretic Hormone Receptor Antagonists; Atrial Fibrillation; Attitude of Health Personnel; Benzazepines; Bronchitis, Chronic; Bronchodilator Agents; Cardiac Pacing, Artificial; Diabetes Mellitus; Endocarditis, Bacterial; Erythropoietin; Heart Failure; Heparin; Humans; Internal Medicine; Interprofessional Relations; Medical Staff, Hospital; Myocardial Infarction; Recombinant Proteins; Risk Management; Rosiglitazone; Salmeterol Xinafoate; Thiazolidinediones; Thromboembolism; Tolvaptan; Vasodilator Agents; Ventricular Dysfunction, Left; Workload

2008